Human BioSciences, Inc. USA

Human BioSciences, Inc. USA Producing biotechnology advancements in Kollagen™ wound products for safe, simple, effective use in Human & Animal wound care since 1990.

Human BioSciences (HBS) Inc. is a specialty biotechnology company focused on developing collagen in wound care management. HBS is an integral worldwide developer, manufacturer, and distributor of advanced wound care products, including collagen sheets, particles and gels popularly known as SkinTemp™ II Dressings, Medifil™ II Particles and Collatek™ Gel for Human Use. Kollavet™ Products include col

lage sheets, particles and gel for veterinary use. The headquarters and main production facility is located in Gaithersburg, Maryland. They also have one factory in Ahmedabad, India. It is FDA-compliant and ISO 13485 certified. HBS products are approved to manage burns, scrapes, sores, ulcers, acute and chronic wounds from superficial to deep injuries. Easy application and product compatibility with topical agents and dressings allow product use in a myriad of applications. Human products are currently available with a prescription in clinics, healthcare facilities, and doctor's offices. OTC product line available on Amazon for Animal Use and coming soon for humans. For more information and access to products please contact [email protected] or [email protected].

Advanced pressure injuries often present with deep, irregular wound beds — tunneling, undermining, and exposed tissue th...
08/05/2026

Advanced pressure injuries often present with deep, irregular wound beds — tunneling, undermining, and exposed tissue that flat dressings can't adequately address.

Medifil® II collagen particles conform directly to these complex wound geometries, delivering native collagen where it's needed most — supporting tissue regeneration across all four phases of healing.

Eligible for insurance reimbursement under Medicare and many commercial plans.

Request a sample → https://humanbiosciences.com/get-a-sample/ | [email protected]

Pressure injuries affect an estimated 2.5 million patients annually in the U.S. alone — and the majority are preventable...
08/03/2026

Pressure injuries affect an estimated 2.5 million patients annually in the U.S. alone — and the majority are preventable.

Understanding the staging system is critical for clinicians to intervene early, select the right treatment approach, and prevent progression. From non-blanchable redness (Stage 1) to full-thickness tissue loss (Stage 4), each stage demands a different clinical response.

Prevention remains the gold standard — but when pressure injuries do occur, advanced wound care makes the difference.

Explore our wound care solutions → https://humanbiosciences.com/collagen-wound-care-products/ | [email protected]

Real outcomes from real clinicians. A leading plastic and cosmetic surgeon at Kokilaben Dhirubhai Ambani Hospital in Nav...
07/31/2026

Real outcomes from real clinicians.

A leading plastic and cosmetic surgeon at Kokilaben Dhirubhai Ambani Hospital in Navi Mumbai has been using SkinTemp® II for burn care for over 9 years — reporting faster healing rates, excellent patient tolerance (particularly with children suffering scald burns), and significantly fewer dressing changes required.

When clinicians trust a product for nearly a decade, the results speak for themselves.

Read more testimonials → https://humanbiosciences.com/woundcaretestimonials/ | [email protected]

In burn wound management, the dressing needs to do more than cover — it needs to actively support healing while allowing...
07/29/2026

In burn wound management, the dressing needs to do more than cover — it needs to actively support healing while allowing breathability and fluid control.

SkinTemp® II has been trusted by plastic surgeons for over a decade in burn care. Its porous collagen sheet format provides breathable coverage for partial-thickness burns, donor sites, and post-excision wound beds — with clinicians reporting faster healing, reduced dressing frequency, and excellent patient tolerance.

Built with Kollagen™ Technology. Eligible for reimbursement.

Request a SkinTemp® II sample → https://humanbiosciences.com/get-a-sample/ | [email protected]

Burns can create some of the most complex and long-lasting wounds in clinical practice. Burn classification determines t...
07/27/2026

Burns can create some of the most complex and long-lasting wounds in clinical practice.

Burn classification determines treatment approach, and understanding the depth of injury is critical for clinicians making decisions about dressing selection, surgical intervention, and long-term care planning.

From superficial burns affecting only the epidermis to full-thickness injuries destroying the entire dermis, each level demands a different clinical response.

Learn about collagen solutions for burn care → [email protected]

In global healthcare procurement, quality, regulatory compliance, and supply reliability are what win tenders — and U.S....
07/24/2026

In global healthcare procurement, quality, regulatory compliance, and supply reliability are what win tenders — and U.S.-made collagen products consistently deliver on all three.

In this article, we explore why collagen wound care products manufactured in the USA hold a competitive advantage in international tenders, and what healthcare buyers and distributors should look for when evaluating suppliers.

Read the full article on our website. https://humanbiosciences.com/woundcareblog/why-u-s-made-collagen-wins-tenders-globally/

In competitive healthcare procurement environments, particularly in government and institutional tenders, decision-makers prioritize products that demonstrate consistent quality, regulatory compliance, and long-term reliability. Across global markets, collagen-based medical products manufactured in....

A 55-year-old male patient had been suffering from painful vasculitis for over 4 months — and was reluctant to wear comp...
07/23/2026

A 55-year-old male patient had been suffering from painful vasculitis for over 4 months — and was reluctant to wear compression therapy.

His vascular surgeon chose Medifil® II Kollagen™ particles, applying them directly to the wound bed. The result: complete wound closure in just 6 weeks.

Case study conducted by Dr. G. Marunraj, M.B., B.S., M.S., M.Ch., Vascular Surgeon, Kanchipuram, India.

This is the kind of outcome that reinforces why collagen-based wound care matters — especially for chronic vascular wounds.

View more case studies → https://humanbiosciences.com/wound-care-case-studies/ | [email protected]

Vascular ulcers are often chronic, painful, and slow to respond to conventional treatment. Medifil® II collagen particle...
07/22/2026

Vascular ulcers are often chronic, painful, and slow to respond to conventional treatment.

Medifil® II collagen particles are ideal for deeper vascular wounds — conforming to the wound bed and providing a native collagen scaffold that supports tissue regeneration. For wounds that are dry or have tunneling areas, Collatek® Gel donates moisture to the wound bed while delivering collagen directly where it's needed.

Both products support the healing process across all four phases and are eligible for insurance reimbursement.

If you're managing complex vascular wounds, we'd love to discuss how our products can fit your treatment protocol.

Request samples → https://humanbiosciences.com/get-a-sample/ | [email protected]

Vascular ulcers — wounds caused by diseases of the veins and arteries — require fundamentally different management appro...
07/20/2026

Vascular ulcers — wounds caused by diseases of the veins and arteries — require fundamentally different management approaches, and misdiagnosis can do more harm than good.

Venous ulcers account for up to 80% of leg ulcers and are characterized by shallow wounds with heavy exudate. Arterial ulcers, caused by peripheral arterial disease, are typically deeper with minimal drainage.

Understanding the underlying vascular pathology is essential before selecting a treatment strategy. Swipe through for a clinical overview of both types.

Discuss vascular wound care solutions with our team → [email protected]

Diabetic foot ulcers are a major healthcare burden in India, where diabetes prevalence continues to rise. Collagen-based...
07/17/2026

Diabetic foot ulcers are a major healthcare burden in India, where diabetes prevalence continues to rise. Collagen-based wound therapies are proving to be an effective approach in Indian hospital settings — supporting faster healing and reducing the risk of complications that can lead to amputation.

In this article, we explore how Indian hospitals are using collagen dressings to treat diabetic ulcers and the clinical outcomes they're achieving.

Read the full article on our website. https://humanbiosciences.com/woundcareblog/diabetic-ulcer-treatment-with-collagen-in-indian-hospitals/

Diabetic ulcers represent one of the most serious and common complications of diabetes, particularly in countries with large diabetic populations. In India, where diabetes prevalence continues to rise, diabetic foot ulcers are a frequent reason for hospital visits and long-term wound care treatment....

Address

600 N Queen Street
Martinsburg, WV
25404

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Alerts

Be the first to know and let us send you an email when Human BioSciences, Inc. USA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Human BioSciences, Inc. USA:

Shortcuts

Share